NF-κB/STAT3/PI3K signaling crosstalk in iMycEμ B lymphoma

被引:96
作者
Han, Seong-Su [1 ]
Yun, Hwakyung [2 ]
Son, Dong-Ju [1 ]
Tompkins, Van S. [1 ]
Peng, Liangping [3 ]
Chung, Seung-Tae [4 ]
Kim, Joong-Su [5 ,6 ]
Park, Eun-Sung [7 ]
Janz, Siegfried [1 ]
机构
[1] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA
[2] Hanseo Univ, Dept Biol Sci, Choognam, South Korea
[3] Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, Newark, NJ 07103 USA
[4] Korea Food & Dug Adm, Natl Inst Toxicol Res, Seoul, South Korea
[5] Korea Res Inst Biosci, Taejon, South Korea
[6] Korea Res Inst Biotechnol, Taejon, South Korea
[7] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA
关键词
NF-KAPPA-B; C-MYC; CELL LYMPHOMA; DOWN-REGULATION; SERINE PHOSPHORYLATION; MULTIPLE-MYELOMA; PI3K/AKT PATHWAY; UP-REGULATION; STAT3; ACTIVATION;
D O I
10.1186/1476-4598-9-97
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Background: Myc is a well known driver of lymphomagenesis, and Myc-activating chromosomal translocation is the recognized hallmark of Burkitt lymphoma, an aggressive form of non-Hodgkin's lymphoma. We developed a model that mimics this translocation event by inserting a mouse Myc cDNA gene into the immunoglobulin heavy chain locus, just upstream of the intronic E mu enhancer. These mice, designated iMyc(E mu), readily develop B-cell lymphoma. To study the mechanism of Myc-induced lymphoma, we analyzed signaling pathways in lymphoblastic B-cell lymphomas (LBLs) from iMyc(E mu) mice, and an LBL-derived cell line, iMyc(E mu)-1. Results: Nuclear factor-kappa B (NF-kappa B) and signal transducer and activator of transcription 3 (STAT3) were constitutively activated in iMyc(E mu) mice, not only in LBLs but also in the splenic B-lymphocytes of young animals months before tumors developed. Moreover, inhibition of either transcription factor in iMyc(E mu)-1 cells suppressed growth and caused apoptosis, and the abrogation of NF-kappa B activity reduced DNA binding by both STAT3 and Myc, as well as Myc expression. Inhibition of STAT3 signaling eliminated the activity of both NF-kappa B and Myc, and resulted in a corresponding decrease in the level of Myc. Thus, in iMyc(E mu)-1 cells NF-kappa B and STAT3 are co-dependent and can both regulate Myc. Consistent with this, NF-kappa B and phosphorylated STAT3 were physically associated with one another. In addition, LBLs and iMyc(E mu)-1 cells also showed constitutive AKT phosphorylation. Blocking AKT activation by inhibiting PI3K reduced iMyc(E mu)-1 cell proliferation and caused apoptosis, via downregulation of NF-kappa B and STAT3 activity and a reduction of Myc levels. Co-treatment with NF-kappa B, STAT3 or/and PI3K inhibitors led to additive inhibition of iMyc(E mu)-1 cell proliferation, suggesting that these signaling pathways converge. Conclusions: Our findings support the notion that constitutive activation of NF-kappa B and STAT3 depends on upstream signaling through PI3K, and that this activation is important for cell survival and proliferation, as well as for maintaining the level of Myc. Together, these data implicate crosstalk among NF-kappa B, STAT3 and PI3K in the development of iMyc(E mu) B-cell lymphomas.
引用
收藏
页数:17
相关论文
共 83 条
[1]
THE C-MYC ONCOGENE DRIVEN BY IMMUNOGLOBULIN ENHANCERS INDUCES LYMPHOID MALIGNANCY IN TRANSGENIC MICE [J].
ADAMS, JM ;
HARRIS, AW ;
PINKERT, CA ;
CORCORAN, LM ;
ALEXANDER, WS ;
CORY, S ;
PALMITER, RD ;
BRINSTER, RL .
NATURE, 1985, 318 (6046) :533-538
[2]
Overexpressed nuclear factor-κB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPβ and signal transducer and activator of transcription-3 [J].
Agrawal, A ;
Cha-Molstad, H ;
Samols, D ;
Kushner, I .
IMMUNOLOGY, 2003, 108 (04) :539-547
[3]
MOLECULAR-CLONING OF APRF, A NOVEL IFN-STIMULATED GENE FACTOR-3 P91-RELATED TRANSCRIPTION FACTOR INVOLVED IN THE GP130-MEDIATED SIGNALING PATHWAY [J].
AKIRA, S ;
NISHIO, Y ;
INOUE, M ;
WANG, XJ ;
WEI, S ;
MATSUSAKA, T ;
YOSHIDA, K ;
SUDO, T ;
NARUTO, M ;
KISHIMOTO, T .
CELL, 1994, 77 (01) :63-71
[4]
NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[5]
Baohua Yu, 2008, Diagn Mol Pathol, V17, P159, DOI 10.1097/PDM.0b013e31815d0588
[6]
Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells [J].
Bargou, RC ;
Emmerich, F ;
Krappmann, D ;
Bommert, K ;
Mapara, MY ;
Arnold, W ;
Royer, HD ;
Grinstein, E ;
Greiner, A ;
Scheidereit, C ;
Dörken, B .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (12) :2961-2969
[7]
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression [J].
Basseres, D. S. ;
Baldwin, A. S. .
ONCOGENE, 2006, 25 (51) :6817-6830
[8]
Activation of AKT kinases in cancer: Implications for therapeutic targeting [J].
Bellacosa, A ;
Kumar, CC ;
Di Cristofano, A ;
Testa, JR .
ADVANCES IN CANCER RESEARCH, VOL 94, 2005, 94 :29-+
[9]
Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia:: Frequent PIK3CA amplification and AKT phosphorylation [J].
Bertelsen, BI ;
Steine, SJ ;
Sandvei, R ;
Molven, A ;
Laerum, OD .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (08) :1877-1883
[10]
Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells [J].
Bhardwaj, Anjana ;
Sethi, Gautam ;
Vadhan-Raj, Saroj ;
Bueso-Ramos, Carlos ;
Takada, Yasunari ;
Gaur, Upasna ;
Nair, Asha S. ;
Shishodia, Shishir ;
Aggarwal, Bharat B. .
BLOOD, 2007, 109 (06) :2293-2302